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ABSTRACT MK-801, a noncompetitive antagonist of the NMDA (N-methyl-D-aspartate) receptor, has protective effects against
excitotoxicity and ethanol withdrawal seizures. We have determined membrane/buffer partition coefficients (kplmem]) of MK-801
and its rates of association with and dissociation from membranes. Kpimem1 (±SD) = 1137 (±320) in DOPC membranes and
485 (±99) in synaptoneurosomal (SNM) lipid membranesfrom rat cerebral cortex (unilamellarvesicles). In multilamellarvesicles,
Kplmem] was higher: 3374 (±253) in DOPC and 6879 (±947) in SNM. In cholesterol/DOPC membranes, Kp1memi decreased as
the cholesterol content increased. MK-801 associated with and dissociated from membranes rapidly. Addition of ethanol to SNM
did not affect KpImemp MK-801 decreased the cooperative unit size of DMPC membranes. The decrease was smaller than that
caused by 1,4-dihydropyridine drugs, indicating a weaker interaction with the hydrocarbon core. Small angle x-ray diffraction,
with multilayer autocorrelation difference function modeling, indicated that MK-801 in a cholesterol/DOPC membrane (mole ratio
= 0.6) causes a perturbation at -16.0 A from the bilayer center. In bilayers of cholesterol/DOPC = 0.15 (mole ratio) or pure
DOPC, the perturbation caused by MK-801 was more complex. The physical chemical interactions of MK-801 with membranes
in vitro are consistent with a fast onset and short duration of action in vivo.
INTRODUCTION
MK-801 (dizocilpine; (5R, 10S)-(+)-5-methyl-10,11-dihy-
dro-5H-dibenzo[a,d]cyclohepten-5,10-imine) is a noncom-
petitive antagonist of the NMDA (N-methyl-D-aspartate) re-
ceptor (Wong et al., 1986), a subtype of glutamate receptor
that is associated with a cation channel. The chemical struc-
ture of MK-801 is shown in Fig. 1. The (+)-isomer (shown)
is more active than the (-)-isomer. The NMDA receptor-ion
channel complex has several binding sites, including sites for
1) agonists (i.e., glutamate, NMDA), 2) glycine, 3) phen-
cyclidine (PCP), 4) Mg2+, 5) Zn2+, and 6) polyamines
(Kozikowski et al., 1989). MK-801 binds to the PCP-binding
site, which is believed to lie within the ion channel, deep
enough to be at the level of the hydrophobic core of the
membrane bilayer (Sakurada et al., 1993). Thus, efficiency
of interaction of MK-801 with its receptor could be affected
by the structure and composition of the membrane, especially
by the concentration and distribution of membrane choles-
terol. MK-801 is known to penetrate the central nervous sys-
tem (Wong et al., 1986). It is thought to approach its specific
binding site through the open cation channel, because the
presence of an agonist is required for MK-801 binding
(Foster and Wong, 1987; Reynolds and Miller, 1988). The
NMDA receptor complex has been implicated in excitotox-
icity caused by ischemia, hypoglycemia, and other causes,
and antagonists of this receptor, including MK-801, have
been shown to have neuroprotective effects (Gill et al., 1988;
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Schwartz and Meldrum, 1986, Tasker et al., 1992; el-Asrar
et al., 1992). MK-801 appears to protect against other types
of neurotoxicity as well, such as that induced in dopamin-
ergic systems by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine) (Tabatabaei et al., 1992; Zuddas et al., 1992).
It has anticonvulsant and sympathomimetic effects and may
also have anxiolytic properties (Clineschmidt et al., 1982a-c;
Xie and Commisaris, 1992; Rupniak et al., 1993). The action
of agonists at the NMDA receptor is inhibited by acute etha-
nol administration (Hoffman et al., 1990; Lovinger et al.,
1990). This receptor is up-regulated after chronic ethanol
consumption and is involved in the generation of withdrawal
seizures (Grant et al., 1990). MK-801 can prevent the de-
velopment of tolerance to ethanol, cocaine, and morphine
(Khanna et al., 1992; Wu et al., 1993; De Montis et al., 1992;
Trujillo and Akil, 1991) and can reduce the severity of etha-
nol withdrawal seizures (Grant et al., 1990). Because MK-
801 or similar agents could eventually be useful in prevention
or treatment of the conditions discussed here, knowledge of
its interaction with the membrane would be useful for the
design of new drugs with optimal membrane/receptor prop-
erties. We have investigated the interaction of MK-801 with
native and model membranes, especially with regard to the
effects of membrane cholesterol content.
MATERIALS AND METHODS
Materials
Phospholipids were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL).
Cholesterol, assay reagents, salts, solvents, and buffers were obtained from
Sigma Chemical Co. (St. Louis, MO). [3H]MK-801 and ["4C]DOPC were
purchased from NEN Research Products (Boston, MA). Whatman GF/C
glass fiber filters (FP-205) were obtained from Brandel (Biomedical Re-
search and Development Laboratories, Gaithersburg, MD).
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some bi-, tri-, and polylamellar vesicles as well as ULV (Rhodes et al.,
1992). However, it approximates homogeneous ULV closely enough that
any significant differences in partition coefficients from those determined
in MLV are observable.
Membrane/buffer partition coefficients (Kp[mem):
association and dissociation rates of MK-801
from membranes
MK-801
FIGURE 1 The chemical structure of MK-801. MK-801 is a bulky, rigid
molecule with a single nitrogen atom that can be protonated. The more
active, (+)-isomer is shown. The unlabeled form used in this work was the
hydrogen maleate. The radiolabeled form was probably the acetate.
Preparation of SNM and extraction of SNM lipids
SNM were prepared from rat cerebral cortex by a modification of the origi-
nal method (Hollingsworth et al., 1985) as previously reported (Moring
et al., 1991). Male Sprague-Dawley rats were obtained from Zivic-Miller
(Zelienople, PA). Protein concentration was assayed by the method of
Lowry et al. (1951); phospholipid concentration was estimated from the
inorganic phosphate content as determined by the method of Chen et al.
(1956).
Lipid extraction was performed by the method of Sun and Lin (1989).
In an acid-washed glass centrifuge tube, 4 vol of 2/1 (v/v) chloroform/
methanol was added to the SNM preparation. The mixture was vortexed and
centrifuged for 2 min at low speed to separate the phases (setting 5, IEC
Clinical Centrifuge, International Equipment Co., Needham Heights, MA).
The organic phase was removed to another tube. Two vol (original prepa-
ration) of 2/1 chloroform/methanol, 0.4% HCl, was added to the aqueous
phase, and the mixture was vortexed and centrifuged as before. The organic
phase was neutralized with one drop of 4N NH40H and vortexed. The
organic phases were combined, evaporated to dryness under a stream of
nitrogen, and immediately reconstituted to 2 2/3 times the volume of the
original SNM preparation using 2/1 chloroform/methanol. Phospholipid
concentration was estimated from inorganic phosphate content determined
by the method of Chen et al. (1956). Cholesterol content of the lipid extracts
was assayed enzymatically by the method of Heider and Boyett (Heider and
Boyett, 1978) as modified by Chester (Chester et al., 1986).
Preparation of lipid vesicles for partition
coefficients
Multilamellar lipid vesicles (ML V)
Thin films were made in test tubes by the method of Bangham et al. (1965).
2p,mol of dioleoylphosphatidylcholine (DOPC) (or 2 mg of extracted lipids,
or cholesterol/2 ,Lmol of DOPC in various mole ratios) dissolved in 19/1
chloroform/methanol was dried under a stream of nitrogen while being vor-
texed to form a thin film. The film was kept under vacuum for 30 min; then
1 ml of buffer (150 mM NaCl, 10 mM Tris, pH 7.0) was added while the
tube was vortexed to form a suspension of vesicles. 50 Ll of this suspension
was used per sample for Kp[meml measurements.
Unilamellar lipid vesicles (ULV)
ULV were made from MLV using the Lipo-So-Fast apparatus (MM De-
velopments, Toronto, Ontario, Canada). 1 ml at a time of the MLV sus-
pension was passed back and forth 13 times through a 100 nm filter and
expelled after the 14th pass (a total of 27 passes through the filter). The
suspension of vesicles resulting from this procedure is a mixture containing
Details of the methods for these related experiments have been previously
described (Herbette et al., 1989). Brief summaries are given below.
Kp[mem]
Kp[memjS of MK-801 into membranes were measured by vacuum filtration
(Brandel MR-48R cell harvester, Biomedical Research and Development
Laboratories, Gaithersburg, MD) using [3H]MK-801. The amount of mem-
brane phospholipid retained on the filter during filtration was measured by
means of vesicles radiolabeled with [14C]DOPC or [3H]cholesterol. Cho-
lesterol is retained proportionately to phospholipid, and retention does not
change with cholesterol content (Rhodes et al., 1992). Membrane/buffer
partition coefficients (Kp[mem.) were calculated using the following equation:
Kp[memj = (g of MK-801 bound to membrane/g of membrane phospholipid)/
(g of MK-801 in filtrate/g of buffer).
Association
Nonspecific binding rates of [3H]MK-801 to model and native membrane
lipid vesicles were measured at 25°C at various time points from 15 s to 90
min. Solutions of [3H]MK-801 (1.5 nM) and 12.5 jig/ml membrane in a pH
7.3 buffer (10 mM Tris, 150 mM NaCl) were filtered through glass fiber
filters on a Brandel cell harvester. Because we were measuring nonspecific
rather than specific binding of MK-801, the filters were not washed after
filtration but were immediately counted for MK-801. Reaction mixtures
containing MK-801 but no membrane were used to measure MK-801 bind-
ing directly to the filters. The number of radioactive counts of MK-801
detected on the filters was used, after correction for binding directly to the
filters, to represent the amount of MK-801 bound to membranes. This num-
ber and the number of grams of lipid recovered on the filters were used for
calculations. The amount of [3H]MK-801 remaining in the filtrate was de-
termined by subtraction.
Dissociation
Mixtures containing [3H]MK-801 (1.5 nM) and 12.5 ,ug/ml membranes in
a pH 7.3 buffer (10mM Tris, 150mM NaCl) were filtered through Whatman
GF/C glass fiber filters on a Brandel cell harvester. The filters were not
washed after filtration. Control reaction mixtures contained radiolabeled
MK-801 but no membranes. Filters with membranes and control filters (no
membrane) were immediately counted for radioactivity to find the maximal
binding of MK-801 to membranes. The remaining filters were placed in a
beaker containing buffer at 25°C. At appropriate time intervals, filters with
and without membranes were taken out of the buffer and assayed for ra-
dioactivity. The percent of [3H]MK-801 remaining bound to membranes at
each time point was calculated.
Measurement of change in cooperative unit size
Sample preparation
Multilamellar vesicles of DMPC were produced by drying 100 ,ul aliquots
of a 0.03 M solution of lipid in chloroform to a thin film by evaporation
under N2, with the residual solvent being removed by overnight evacuation.
The lipid was then rehydrated for 10 min at 50°C with 100 p.l of sample
buffer (0.05 mM HEPES, 150 mM NaCl, pH 7.0) and vortexed for 1 min
CH3
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to produce vesicles. For drug-containing samples, either 5.8 or 2.9 Al of 0.03
M drug solution (to obtain drug/lipid mole ratios of 1/17 or 1/35) was added
to the lipid being dried down, with vesicles being produced as described
above.
Differential scanning calorimetry
Differential scanning calorimetry (DSC) was carried out on drug-containing
and control multilamellar vesicles. 15 l1l aliquots of vesicles containing 300
jig of lipid were placed in DSC sample pans and hermetically sealed. ATA
Instruments DSC 2910 Differential Scanning Calorimeter (Wilmington,
DE) calibrated with an indium standard was used for data collection. A scan
rate of 2°C/min starting from 6°C and going to 29.5°C was used for ex-
periments. The reference was 15 ,ul of sample buffer. TA Instruments Ther-
mal Analyst 2000 software was used for data analysis. The change in co-
operative unit size was determined by the following formula:
(CS AH.h (A HV,h
(CUSH * Fw,dNg (AH * Fw/),'
where ACUS is the change in the cooperative unit size, AVh is the van't
Hoff enthalpy, AH is the calorimetric enthalpy, and Fw is the formula weight
of the lipid undergoing transition.
X-ray diffraction
Sample preparation
Multilamellar vesicles were prepared as described above for Kpimemj, using
a ratio of 250 ,ug of phospholipid/50 ,l1 of buffer. The buffer used was 0.5
mM HEPES, 2.0 mM NaCl, pH 7.3. When drug-containing samples were
being made, the buffer contained sufficient MK-801 hydrogen maleate (Re-
search Biochemicals Inc., Natick, MA) to yield a final MK-801/
phospholipid mole ratio of 1/60 or 1/45. Lipid multibilayer samples for x-ray
diffraction were made by the "spin-dry" technique by a variation (Chester
et al., 1987) of the method of Clark et al. (1980), in which the volatile fluids
in the sample are evaporated completely by the centrifuge vacuum system
during sedimentation as previously reported (Moring et al., 1991). Enough
vesicle preparation to contain 250 ,g of phospholipid was used per sample.
The samples were simultaneously sedimented onto aluminum foil and de-
hydrated, then mounted on a support and allowed to rehydrate over a satu-
rated solution of a salt selected to maintain a given state of hydration.
Data collection and analysis
Diffraction data were collected using an Elliot GX18 rotating anode mi-
crofocus generator (Marconi Avionics) supplying Cu KCY radiation (A =
1.54 A) in conjunction with a fixed-geometry beamline consisting of a single
Franks mirror providing line focus at the detection plane, vertical and hori-
zontal limiting slits, a nickel filter, the curved specimen, a tungsten beam-
stop, and electronic detection. The beam height at the specimen was - 1 mm.
Data collection was carried out with a Braun one-dimensional, position-
sensitive proportional counter (Innovative Technology, Inc., Newburyport,
MA). Data were transferred to aVAX 8200 (Digital Equipment Corporation,
Maynard, MA) for reduction and analysis. Phases were determined by
means of a swelling series. Perturbations caused by the presence ofMK-801
were determined using electron density differences in conjunction with au-
tocorrelation analysis (Young et al., 1992).
RESULTS
Kp1mem1 in 0.6 cholesterol/DOPC (mole ratio) MLV did not
vary significantly over a range of MK-801 concentrations
from 1.5 x 10-1l M to 4.5 X 10- M (Table 1). Thus, the
nonspecific binding was not saturable over this concentration
range. A physiologically reasonable MK-801 concentration
TABLE 1 Kp[memJ of MK-801 In model membrane vesicles
(±tSD)
Kp[memj in MLV
(cholesterolVDOPC
[MK-801] (M) mole ratio = 0.6)
1.5X 10" 845 (±435)
4.5X10" 913 (±69)
l.5X10-10 740 (+403)
4.5X 10-10 715 (±355)
1.5X 10-9 661 (±264)
4.5X 10-9 790 (±86)
of 1.5 nM, which is near the dissociation constant for specific
binding (Kd) of MK-801, was chosen at which to conduct
further experiments.
Increasing the cholesterol/DOPC mole ratio markedly de-
creased Kp[meml in a concentration-dependent manner, indi-
cating that MK-801 and cholesterol compete for the same
space in the lipid bilayer (Table 2). The amount ofDOPCwas
kept constant throughout; the additional cholesterol in-
creased the total amount of lipid per sample. Our Kp[mem]
calculations have been carried out on the basis of the amount
of phospholipid in the bilayer; cholesterol content was ig-
nored. However, the effect of including cholesterol as well
as phospholipid in the total lipid used in the Kp[mem] calcu-
lations would tend to make Kp[mem] even lower than the values
reported here.
Kp[mem] varied considerably among MLV of different lipid
systems (Table 3). The cholesterol/phospholipid mole ratio
of SNM lipid extract is about 0.6; enough cholesterol was
added to the other systems to yield that mole ratio. The lipid
systems that contain diverse lipid headgroups and/or diverse
acyl chains (i.e., SNM lipid extract and BPC) yielded higher
Kp[meml5 for MK-801 inMLV than did the more homogeneous
systems. In every case, Kp[meml was significantly higher in
MLV than in ULV. In fact, the differences among the Kp[mem]S
for the various lipid systems disappeared when ULV were
used. Trapping of MK-801 between the layers of MLV, pos-
sibly by a pH gradient mechanism (Cullis et al., 1991) and/or
a difference in radius of curvature between MLV and ULV
might be responsible for the higher Kp[memjS in MLV. The
diameter of MLV made by our method is 100-500 nm; that
of ULV is -100 nm (Rhodes et al., 1992).
In MLV, Kp[mem] may vary with pH, especially for MK-
801, the nitrogen atom of which can be protonated and thus
would carry a charge. Our data showed a decrease in Kp[mem]
TABLE 2 Effect of cholesterol content on Kp.,,] of MK-801
(1.5 nM) in cholesterol/DOPC vesicles
Mole ratio Kp[mem] (+ SD) Kp[memi (± SD)
cholesterol/DOPC in MLV in ULV
0.00 3374 (±253) 1137 (±320)
0.15 1040 (±53) 1080 (±38)
0.30 1156 (±129) 862 (±219)
0.45 963 (±166) 802 (±72)
0.60 804 (±82) 582 (±138)
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TABLE 3 KpI,] of MK-801 (1.5 nM) in vesicles of various
lipids + cholesterol
Lipid system
(cholesterol/lipid mole Kp[mem] (±SD) Kptmemj (±SD)
ratio = 0.6) (MLV) (ULV)
SNM lipid extract
(no additional cholesterol) 6879 (±947) 485 (±99)
Bovine phosphatidylcholine (BPC) 2704 (±961) 364 (±49)
Dioleoylphosphatidylcholine (DOPC) 746 (±65) 421 (±25)
at higher pH in MLV (Table 4). However, all of our Kp[mem]S
were determined at pH 7.0, at which MK-801 is probably
highly protonated.
MK-801 is not sufficiently water-soluble that stock solu-
tions can be made in buffer. The [3H]MK-801 stock solutions
were made up in ethanol; therefore, some ethanol was present
in all experiments. Addition of ethanol to SNM preparations
(with 1.5 nM MK-801) in concentrations as high as 0.11 M
in addition to the ethanol present in the stock solutions did
not change Kp[mem] (data not shown). The highest concen-
tration of ethanol in any incubation mixture (without addi-
tional ethanol) was 0.064 M, and the lowest was 3.5 X 10-'
M; the usual concentration was 8.3 X 10-4M (for [MK-801]
= 1.5 nM). Thus, ethanol did not appear to alter Kp[mem] in
these experiments. These data indicate that nonspecific bind-
ing ofMK-801 either is not an interaction with the membrane
surface or is a surface interaction that is simply unaffected
by the presence of ethanol with its attendant effects on hy-
drogen bonding in the hydrated region.
To measure Kp[mem] of MK-801 in intact biological mem-
branes, we used a synaptoneurosome (SNM) preparation.
Table 5 shows that Kp[mem] was constant over a wide range
of MK-801 concentrations, indicating that a true partition
coefficient had been measured; that is, no observable specific
binding had occurred. Nevertheless, an attempt was made to
use literature values of the dissociation constant (Kd) and the
maximum number of binding sites (Bm.) to correct for spe-
cific binding. The Kd of MK-801 in rat cortical membranes
has been measured at 37.2 + 2.7 nM; the maximum number
of binding sites (Bma) was 0.825 ± 0.102 pmol/mg protein
(Wong and Woodruff, 1986). This experiment appears to
have been conducted in the absence of exogenous NMDA
receptor agonists. Other experiments using rat cortex, con-
ducted in the presence of the agonists glutamate and glycine,
TABLE 4 Effect of pH on Kp,,[m,] in MLV (mole ratio
cholesteroVDOPC = 0.6)
pH Kp[mem]
7.0 523 (±164)
8.0 211 (±251)
9.0 293 (±132)
10.0 160 (±66)
11.0 132 (±292)
yield Kd 1-4 nM, although Bm. is not significantly dif-
ferent (Kloog et al., 1988; Steele et al., 1991). The correction
caused Kp[mem] to go to zero at higher MK-801 concentrations,
a further indication that no specific binding occurred in the
SNM preparation. Thus, the true Kp[meml is close to the un-
corrected value. Kp[meml in SNM was about the same as in
ULV of model membrane systems containing 0.6
cholesterol/DOPC (Table 2).
Change in cooperative unit size
Differential scanning calorimetry was used to assess the ef-
fect of various concentrations of MK-801 on membrane dis-
order by measuring the change in the cooperative unit size
(ACUS) of dimyristoylphosphatidylcholine (DMPC) bilay-
ers. The decrease in the main phase transition temperature
(ATm) was also measured. The effect of MK-801 was com-
pared with those of the 1,4-dihydropyridine calcium channel
antagonists nifedipine and nimodipine (Table 6). A decrease
in CUS indicates an increase in bilayer disorder. All three
drugs caused decreases in CUS and Tm in a concentration-
dependent manner. Both of the dihydropyridines caused
larger changes than did MK-801. Thus, MK-801 perturbed
the hydrocarbon core of the bilayer, but less than the dihy-
dropyridines did. This indicates a relatively weak interaction
of MK-801 with the membrane.
Kinetics of MK-801 association with and
dissociation from membranes
Association ofMK-801 with model membranes (cholesterol/
DOPC = 0.6) was rapid (Fig. 2 A), being complete in less
than 5 min. Similarly, dissociation was complete within 10
min (Fig. 3 A). Although such fast association of drugs with
membranes is common, the dissociation rate of MK-801 is
TABLE 5 Kpim,.] of MK-801 in intact synaptoneurosomes
[MK-801] Proportion of receptors Kp[mem] KP[memj(M) ocCupied* (including specific binding) corrected for specific binding
4.5 X 10-11 1.2 X 10-3 (±8.8 X 10-5) 247 (±200) 209 (±144)
1.5 X 10-10 4.0 X 10-3 (±2.9 X 104) 430 (±129) 367 (±131)
4.5 X 10-10 0.012 (±8.7 X 10 4) 363 (±115) 326 (±137)
1.5 x 10-9 0.043 (±3.1 X 10-3) 428 (±117) 365 (±118)
4.5 x 10-9 0.11 (±7.8 X 10-3) 386 (±48) 224 (±52)
1.5 X 10-8 0.29 (±0.029) 354 (±194) 0
4.5 X 10-8 0.55 (±0.040) 191 (±160) 0
1.5 X 10-7 0.80 (±0.058) 250 (±82) 0
* Receptor occupancy calculated according to Y = (1/KD)[A](1-Y), where Y = proportion of receptors occupied; [A] = concentration of MK-801 (M);
KD = dissociation constant (M); KD = 37.2 nM, Bmax = 0.825 PmOomgPrOtein (Wong et al., 1986).
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TABLE 6 Change In cooperative unit size of DMPC caused by presence of MK-801
MK-801 Nifedipine Nimodipine
Drug/DMPC mole ratio 1:35 1:17 1:35 1:17 1:35 1:17
A Tm (OC)* -0.13 -0.71 -1.07 -1.42 -0.76 -1.76
A Cooperative unit size (molecules) -52 -92 -111 -168 -79
-132
* Tm = temperature of main phase transition (°C).
Control DMPC: Tm = 23.05°C; cooperative unit size = 220 molecules.
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FIGURE 2 Kinetics of association ("Wash-in" studies). (A) Association
of MK-801 with cholesterol/DOPC vesicles. (Ef)MLV; (U), ULV; phos-
pholipid concentration = 12.5 i.g/ml, cholesterol/DOPC mole ratio = 0.6,
[MK-801] = 1.5 nM. (B) Association ofMK-801 with intact SNM (not lipid
extract). [MK-801] = 1.5 nM. Wash-in was rapid in both cases, but more
MK-801 entered the cholesterol/DOPC vesicles.
relatively fast compared with some other drugs tested in this
laboratory (Rhodes et al., 1992; Herbette et al., 1986). The
rapid dissociation suggests that although the drug is only
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FIGURE 3 Kinetics of dissociation ("Washout" studies). (A) Dissocia-
tion of MK-801 from cholesterol/DOPC vesicles. (E), MLV; (K), ULV;
phospholipid concentration = 12.5 jig/ml, cholesterol/DOPC mole ratio =
0.6, [MK-801] = 1.5 nM. (B) Dissociation ofMK-801 from intactSNM (not
lipid extract). [MK-801] = 1.5 nM. Most of the MK-801 washed out of
cholesterol/DOPC vesicles within 5 min. Washout from synaptoneurosomes
was slower, possibly because of their protein content.
slightly water-soluble, its location in the membrane is prob-
ably within or very close to the hydrated region, easily ac-
cessible to the interbilayer water space. Similar experiments
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were carried out using intact SNM (not vesicles made from
lipid extract). Figs. 2 B and 3 B show that rates of MK-801's
association with and dissociation from SNM are similarly
fast.
X-ray diffraction
Three cholesterol/DOPC mole ratios, 0.0, 0.15, and 0.60,
were used in the model membranes in these experiments. The
highest was chosen to match the experimentally determined
mole ratio in our SNM preparations, and the lowest was used
to maximize the amount of MK-801 entering the bilayer.
Most experiments were carried out at a high state of bilayer
hydration, nominally 96% relative humidity, to approximate
the high hydration of membranes in vivo. Experiments were
conducted at MK-801/DOPC ratios of 1/60 and 1/45 so that
the bilayers examined would be identical in structure except
for the amount of MK-801 present. Under these conditions,
the difference electron density profile should represent only
differences caused by the presence of more MK-801. The
aim was to find the actual equilibrium nonspecific binding
location of MK-801 by using electron density differences and
the autocorrelation function.
Diffraction patterns for cholesterol/DOPC multilayer
samples containing MK-801 typically had four or five orders
at a high hydration state of the membrane, depending on the
amount of cholesterol present. Fig. 4 shows a typical pattern.
MK-801 perturbed cholesterol/DOPC bilayers in a
concentration-dependent manner. These perturbations, al-
though sometimes small and variable in size, occurred con-
sistently over several experiments.
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FIGURE 4 Diffraction pattern from a cholesterol/DOPC multibilayer
sample, mole ratio = 0.6, MK-801/DOPC = 1/45, d = 57.8 A. (inset)
Orders 2, 3, and 4 enlarged for clarity. Data are shown before background
subtraction and Lorentz correction. The relative humidity was nominally
96%. The highest cholesterol/DOPC ratio consistently yielded four orders.
Lower ratios gave four or five orders.
High hydration, high cholesterol
Most of our x-ray analysis was conducted using samples
having cholesterol/DOPC = 0.6 and high hydration. These
samples gave the most consistent data and are most relevant
to the composition and high in vivo hydration state of the
brain membranes of interest. In these samples, the
cholesterol/DOPC bilayer was in the La, phase with both 1/60
and 1/45 MK-801/DOPC (Fig. 5). Increasing the amount of
MK-801 in the bilayer increased the degree of bilayer melt-
ing, as indicated by a less pronounced curve at the acyl chain
region of the profile. It also increased the electron density in
the glycerol back bone-upper acyl chain region somewhat
(Fig. 5). At 0.6 cholesterol/DOPC, most control samples
(without MK-801) showed evidence of phase separation.
Thus, MK-801 in these amounts tended to prevent phase
separation.
Autocorrelation analysis (Young et al., 1992) was used to
model the perturbation caused by MK-801 in these higher
cholesterol samples. The bilayer model was built from two
Gaussians centered at ± 21.37A representing the headgroups
and another of negative amplitude centered at 0 A repre-
senting the methyl trough. A perturbation centered at 16 A
from the center of the bilayer successfully modeled the small
decrease in headgroup spacing and the slight widening of the
headgroups observed at the higher MK-801 concentration.
The other major perturbation, a negative difference centered
in the water space, was ignored in the model. The experi-
mentally determined multilayer difference autocorrelation
0.2
0.1
o
-0.0- .................
-0.1
-0.2
-30 -20 -0o 0 0o 20 30
Distance (Angstroms)
FIGURE 5 Electron density profiles at high hydration and high choles-
terol content (96%, 0.6). Continuous structure factors were calculated and
sampled at d = 59.1 A Solid profile, MK-801/DOPC = 1/60, original d =
59.1 A. Dotted profile, MK-801/DOPC = 1/45, original d = 58.5 A. (-)
Difference. In this and some other experiments, the headgroups were moved
0.8A closer together with more MK-801 present, but sometimes the distance
between headgroups was unchanged. MK-801 appeared to stabilize the bi-
layer. Diffraction from control samples (without MK-801) at this
cholesterol/DOPC mole ratio usually showed phase separation.
I~~~~~~~~~
30000
_
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function and the one calculated from the model are shown in
A Fig. 6. The model, using the single perturbation, reproduces
the major features of the experimental difference autocor-
0.060 / relation function. The perturbation could be shifted no fur-
ther than ±2 A from its 16 A location without serious dis-
agreement between the modeled and experimental difference
autocorrelation functions. The perturbation at 16 A in the
0.030 eetoelectron density profile is likely to be caused by the actual
presence of MK-801 at that location, but it is also possible
that it results indirectly from the presence ofMK-801 at some
0o.ooo- other location in the bilayer.
0
High hydration, intermediate cholesterol
-0.030 The interaction of MK-801 with 0.15 cholesterol/DOPC was
more complicated than its interaction with the higher cho-
lesterol membrane. A typical set of electron density profiles
-0.060
0....21 O 4 0 60
is shown in Fig. 7. The control and MK-801/DOPC = 1/6010 2Distance (Angstroms) profiles were found to be indistinguishable, whereas the MK-
801/DOPC = 1/45 profile represented a different structure.
B 0.200 At this cholesterol/DOPC ratio, the 1/60 and 1/45 structures
were not isomorphous, so the electron density differences
could not be interpreted as being caused by MK-801. As in
experiments using high cholesterol membranes, increasing
0.100- MK-801 content resulted in a more poorly defined glycerol
backbone-acyl chain region of the profile, indicating pro-
gressive degrees of bilayer melting.
'
0.000 High hydration, no cholesterol
According to the Kp[mem] values, more MK-801 should enter
a pure DOPC membrane than a cholesterol-containing
-0.100- DOPC membrane. Higher MK-801 content might help de-
termine the actual nonspecific binding location of MK-801
in the bilayer. However, the interaction of MK-801 with pure
DOPC turned out to be more complex than that with 0.6
cholesterol/DOPC. 1/60 MK-801/DOPC caused an electron
-0.200
-30
-20 -lo 0 1o 20 30 density increase at -9 A from the bilayer center and a de-
Distance (Angstroms)
crease at the methyl trough, as compared with control (Fig.
C 8). This yielded a better defined acyl chain-glycerol back-
bone region of the electron density profile and probably in-
0.018 - dicates that MK-801 is entering the acyl chain region at about
the position where cholesterol would be located. In most
samples, 1/45 MK-801 caused an electron density increase
at the upper acyl chain region similar to that caused by 1/60
MK-801/DOPC. This increase was accompanied by an in-
crease at the methyl trough region. In most experiments, both
0
0 / \ FIGURE 6 Autocorrelation analysis. (A). Experimentally determined dif-
ference autocorrelation function. This difference autocorrelation function
was calculated from the x-ray intensity data used to produce the electron
0.000 density profiles shown in Fig. 5 (high membrane hydration, cholesterol/
DOPC = 0.6, MK-801/DOPC = 1/45 and 1/60). (B) Model electron density
profiles. These electron density profiles model the electron density profiles
shown in Fig. 5. Construction of the model is explained in the text. (C)
10 20 30 40 50 60o Difference autocorrelation function calculated from the models. This func-
Distance (Angstroms) tion reproduces the major features of the experimentally determined func-
tion in Fig. 6 A.
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FIGURE 7 Electron density profiles at high hydration and low cholesterol
content. (96%, cholesterol/DOPC = 0.15). Continuous structure factors
were calculated and sampled at d = 60.4 A. Solid profile, control (no MK-
801), original d = 59.8 A. Dotted profile, MK-801/DOPC = 1/60, original
d = 59.7 A. Dashed profile, MK-801/DOPC = 1/45, original d = 60.4 A.
Repetitions of this experiment showed that the control and MK-801/DOPC
= 1/60 are not different within the experimental error and that 1/45 MK-
801/DOPC is not isomorphous to the other two profiles.
MK-801/DOPC ratios appeared to cause ordering of the bi-
layer, with 1/60 > 1/45. Occasionally, however, 1/45 MK-
801/DOPC caused bilayer melting instead. The higher con-
centration of MK-801 always caused an increase in electron
density in the methyl trough region over that of the lower
concentration, which probably indicates that at 1/45, some
MK-801 is entering the methyl trough region.
Lower hydration states
Some experiments were carried out at lower bilayer hydra-
tion states for the purpose of clarifying the MK-801-
membrane interaction. Although the interactions were better
defined at lower hydration, they were different from those at
higher hydration and therefore were not useful for interpret-
ing the higher hydration state. Nevertheless, some observa-
tions are of interest. At a lower hydration state (nominally
84%, cholesterol/DOPC = 0.6), neither MK-801 concen-
tration increased bilayer melting. The perturbations of the
bilayer by MK-801 were closer to the bilayer center. At 72%
(cholesterol/DOPC = 0.15), the perturbation caused by MK-
801 was -7 A from the bilayer center, probably because of
the lack of excess water in the hydrated region. Only the
higher MK-801 concentration caused bilayer melting.
DISCUSSION
The chemical structure of MK-801 indicates a bulky, rigid
molecule with hydrophobic ring systems and a basic nitrogen
v 0.0
-0.1I
-0.2
-30 -20 -1o 0 1o 20 30
Distance (Angstroms)
FIGURE 8 Electron density profiles at high hydration, no cholesterol
present. Continuous structure factors were calculated and sampled at d =
59.7 A Solid profile, control (no MK-801), original d = 57.1 A. Dotted
profile, MK-801/DOPC = 1/60, original d = 57.9 A. Dashed profile, MK-
801/DOPC = 1/45, original d = 59.5 A. Dashed-dotted line, difference. The
electron density differences in the absence of cholesterol are complex, but
the interpretation that some MK-801 may reach the bilayer center at 1/45
MK-801/DOPC is consistent with the results. At 1/60 acyl chain region
density and headgroup density increase; at 1/45, methyl trough density in-
creases. 1/45 MK-801/DOPC did not necessarily increase the state of melt-
ing of the bilayer over control; thus, MK-801 did not contribute significantly
to bilayer disorder.
atom that is likely to be protonated at physiological pH. Its
Kpimemi, although relatively low, shows that MK-801 enters
lipid bilayers in significant amounts. Its nonspecific equi-
librium binding location in a bilayer of given composition is
likely to depend on the balance between the charge on the
protonated nitrogen atom in the central ring system and the
hydrophobic character of the rings. The decrease of Kp[meml
with increasing pH indicates that the protonation and hy-
drogen bonding capacity of MK-801 are more important de-
terminers of the extent of its nonspecific membrane binding
than its hydrophobic character.
At least two explanations are possible for the decrease
in Kp[mem] with increasing membrane cholesterol content.
1) Cholesterol in relatively low concentrations tends to order
the bilayer. More space for drug molecules is likely to be
available in a disordered bilayer (King et al., 1985). 2) MK-
801 is a rigid, bulky molecule that appears to position itself
preferentially in a region of the membrane in which choles-
terol is located. The cholesterol may be directly displacing
MK-801 from its preferred location in the bilayer.
Ethanol did not affect Kp[meml of MK-801. The lower etha-
nol concentrations in these experiments are physiologically
relevant, although the highest concentration used (0.11 M)
represents a dangerous, possibly lethal concentration in the
blood in vivo. Ethanol is preferentially located in the hy-
drated region of the membrane rather than in the hydrophobic
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core (Herbette et al., 1985). That in vitro ethanol exposure
failed to alter KpImem1 of MK-801 indicates that even at high
hydration states and high cholesterol concentration, this drug
may be somewhat deeper within the hydrophobic region of
the membrane than the perturbation at -16 A from the bi-
layer center that we modeled in our autocorrelation studies.
Electron density profiles were determined at high hydra-
tion because this state is more physiologically relevant than
a lower hydration state. Thus, the in vivo perturbation of
membranes by MK-801 is most likely to be centered in the
glycerol backbone region. Whether the perturbation modeled
at 16 A represents the average equilibrium nonspecific bind-
ing location of actual molecules of MK-801, or is instead the
major perturbation resulting from molecules at another lo-
cation is uncertain. The crystal structure of a compound
closely related to MK-801 has been determined (Leeson
et al., 1990a). Its chemical structure is the same as that of
MK-801 except that there is one more carbon atom, with two
hydrogens, in the central ring system. The crystal structure
parameters and chemical formula (C17H17N) of this com-
pound were used to calculate its electron density (0.39
eCA-3), which approximates the electron density for MK-
801 (C16H15N without its maleate counter ion). Average elec-
tron densities for the phosphate headgroup region (0.43
eCA-3), fatty acyl chain region (0.26 e-A-3), and terminal
methyl region (0.196 e-AO-) of a DPPC bilayer have been
calculated (Trumbore et al., 1988). Using these DPPC elec-
tron densities to approximate those ofDOPC bilayer regions,
we find that the contrast of MK-801 with the headgroup is
insufficient to show the drug directly if it is in the headgroup
region. Cholesterol is located in the glycerol backbone and
upper acyl chain regions of the bilayer (Franks, 1976), where
its presence tends to increase the electron density. The elec-
tron density caused by MK-801 would probably be directly
observable as an increase only in the acyl chain or methyl
trough regions, and perhaps not even in the upper acyl chain
region of a cholesterol-containing bilayer.
The binding of MK-801 to its receptor is slow in the ab-
sence of NMDA receptor agonists (t½, = 70 min), but faster
when glutamate and glycine are present (th = 5-8 min)
(Kloog et al., 1988). (These agonists increase the rates of
association and dissociation, but not Kd.) Thus, the nonspe-
cific association of MK-801 with membranes is on a time
scale similar to that of receptor binding in the presence of
agonists. The perturbation found at 16 A is not as deep in the
membrane as the putative location of the MK-801 binding
site, which is thought to be within the hydrophobic region of
the membrane rather than in the hydrated headgroup region
(Monaghan et al., 1989; Winger, 1987; Sakurada et al.,
1993). Approach to the specific binding site by first parti-
tioning into the membrane and then diffusing laterally toward
the site has been proposed for some drugs (Hille, 1977;
Herbette et al., 1986; Herbette et al., 1989; Rhodes et al.,
1985). The apparent requirement of an open channel for MK-
801 binding and the location of the major perturbation in the
glycerol backbone-upper acyl chain region in the absence of
membrane to the binding site is unlikely for this drug. How-
ever, because specific binding does take place, although ex-
tremely slowly, in the absence of NMDA receptor agonists,
a membrane route might be possible when the channel is
closed. If the receptor is located in a cholesterol-poor mem-
brane domain, MK-801 might penetrate the membrane more
extensively and deeply in the vicinity of the receptor, making
a route through the membrane more likely. In any case, we
speculate that MK-801 in the membrane, nonspecifically
bound in the glycerol backbone region, might create a pool
of MK-801 in equilibrium with drug in the interbilayer water
space. Such a reserve pool might lengthen the time that the
drug is available near the specific binding site and/or increase
the amount available.
The change in glycerol backbone-acyl chain region shape,
increase in bilayer disorder, and lack of extensive alterations
in the acyl chain-methyl trough region of the electron density
profile (cholesterol/DOPC = 0.6) are consistent with, but not
proof of, a glycerol backbone region location of MK-801.
Furthermore, the molecule contains a basic nitrogen atom
that is probably protonated at pH 7.0, and that can hydrogen-
bond (Leeson et al., 1990b). Although the hydrophobicity of
its aromatic systems would tend to place MK-801 in the acyl
chain region of the bilayer, the presence of a positive charge
and hydrogen bonding capability would tend to place the
drug in the hydrated region. We speculate that the MK-801
molecule, like cholesterol, is preferentially located at the in-
terface between the hydrated headgroup region and the hy-
drophobic acyl chain region, with the nitrogen atom in the
hydrated area and the ring system spread out below the in-
terface in the hydrophobic upper acyl chain region. Steri-
cally, such an orientation of MK-801 would be unfavorable,
which might contribute to its surprisingly low Kp[mem]. The
actual equilibrium nonspecific binding location and mem-
brane orientation could probably be determined by neutron
diffraction experiments using deuterated MK-801. The in-
teraction of MK-801 with cholesterol/DOPC membranes as
determined by x-ray diffraction is variable depending on cho-
lesterol content and membrane hydration state. Because of
variations in lipid composition among tissues, particularly in
cholesterol content, the interaction is also likely to be highly
variable in vivo.
The time required for MK-801 to associate with or dis-
sociate from the membrane is similar in MLV, ULV, and
SNM. The fast kinetics are consistent with the relatively low
Kp[mem] (this work) and the quick onset and short-acting na-
ture of MK-801 in vivo (Troupin et al., 1986; Vezzani et al.,
1989). A high Kplmem] is often correlated with a slow rate of
dissociation from the membrane, but not necessarily with a
slow rate of association. Lacidipine, a 1,4-dihydropyridine
calcium channel blocker with a very high partition coeffi-
cient and an equilibrium nonspecific binding location in
the hydrocarbon core, has slow rates of association with
and dissociation from membranes (Herbette et al., 1993).
Lacidipine also has both a long onset time and long duration
of action in vivo. Amiodarone, a long acting antiarrhythmic
a deeper perturbation are evidence that a route through the
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drug with an extremely high Kp[mem] (Herbette et al., 1986;
Moring et al. MK-801 Interaction with Membranes 2385
Trumbore et al., 1988), has a slow rate of membrane
dissociation (Herbette and Gruner, 1987), yet it associates
with the membrane quickly (D. W. Chester, personal
communication).
The major conclusions to be drawn from this work are as
follows:
1) The fast rates of association and dissociation of MK-801
with model and native membranes in vitro are consistent with
a quick onset and short duration of action in vivo.
2) Cholesterol in the membrane interferes in a
concentration-dependent manner with partitioning of MK-
801 into the bilayer.
3) The equilibrium nonspecific binding location of MK-801
in high cholesterol membranes is most likely to be in the
hydrated glycerol backbone-headgroup region. In mem-
branes of lower cholesterol content, MK-801 appears to pen-
etrate more deeply.
4) A route for MK-801 through the membrane to its specific
binding site is unlikely, except perhaps in the absence of
receptor agonists. Nevertheless, MK-801 nonspecifically
bound in the hydrated region or at the hydrophilic-
hydrophobic interface might act as a reserve pool accessible
to the specific binding site through the aqueous region.
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